205 related articles for article (PubMed ID: 37534622)
21. The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
Lucas A; Liu L; Dai E; Bot I; Viswanathan K; Munuswamy-Ramunujam G; Davids JA; Bartee MY; Richardson J; Christov A; Wang H; Macaulay C; Poznansky M; Zhong R; Miller L; Biessen E; Richardson M; Sullivan C; Moyer R; Hatton M; Lomas DA; McFadden G
Adv Exp Med Biol; 2009; 666():132-56. PubMed ID: 20054981
[TBL] [Abstract][Full Text] [Related]
22. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
23. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
24. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin.
Miller LW; Dai E; Nash P; Liu L; Icton C; Klironomos D; Fan L; Nation PN; Zhong R; McFadden G; Lucas A
Circulation; 2000 Apr; 101(13):1598-605. PubMed ID: 10747355
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
[TBL] [Abstract][Full Text] [Related]
27. Acellular Human Amniotic Fluid-Derived Extracellular Vesicles as Novel Anti-Inflammatory Therapeutics against SARS-CoV-2 Infection.
Chanda D; Del Rivero T; Ghimire R; More S; Mitrani MI; Bellio MA; Channappanavar R
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400048
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Infection and C1-Esterase Inhibitor: Camouflage Pattern and New Perspective.
Al-Kuraishy HM; Al-Gareeb AI; Jalal NA; Kabrah SM; Alexiou A; Batiha GE
Curr Protein Pept Sci; 2022; 23(7):465-474. PubMed ID: 35959625
[TBL] [Abstract][Full Text] [Related]
29. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
Front Immunol; 2022; 13():811430. PubMed ID: 35250984
[TBL] [Abstract][Full Text] [Related]
30. Myxoma virus derived immune modulating proteins, M-T7 and Serp-1, reduce early inflammation after spinal cord injury in the rat model.
Kwiecien JM; Dabrowski W; Marzec-Kotarska B; Kwiecien-Delaney CJ; Yaron JR; Zhang L; Schutz L; Lucas AR
Folia Neuropathol; 2019; 57(1):41-50. PubMed ID: 31038187
[TBL] [Abstract][Full Text] [Related]
31. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
Leist SR; Dinnon KH; Schäfer A; Tse LV; Okuda K; Hou YJ; West A; Edwards CE; Sanders W; Fritch EJ; Gully KL; Scobey T; Brown AJ; Sheahan TP; Moorman NJ; Boucher RC; Gralinski LE; Montgomery SA; Baric RS
Cell; 2020 Nov; 183(4):1070-1085.e12. PubMed ID: 33031744
[TBL] [Abstract][Full Text] [Related]
32. Serpins for diagnosis and therapy in cancer.
Zheng D; Chen H; Davids J; Bryant M; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
[TBL] [Abstract][Full Text] [Related]
33. Serpins: Development for Therapeutic Applications.
Lucas A; Yaron JR; Zhang L; Macaulay C; McFadden G
Methods Mol Biol; 2018; 1826():255-265. PubMed ID: 30194606
[TBL] [Abstract][Full Text] [Related]
34. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
Front Immunol; 2022; 13():888897. PubMed ID: 35663932
[TBL] [Abstract][Full Text] [Related]
35. Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model.
Richardson M; Liu L; Dunphy L; Wong D; Sun Y; Viswanathan K; Singh G; Lucas A
Cardiovasc Pathol; 2007; 16(4):191-202. PubMed ID: 17637427
[TBL] [Abstract][Full Text] [Related]
36. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
37. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
[TBL] [Abstract][Full Text] [Related]
38. Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury.
Beladi RN; Varkoly KS; Schutz L; Zhang L; Yaron JR; Guo Q; Burgin M; Hogue I; Tierney W; Dobrowski W; Lucas AR
Curr Neuropharmacol; 2021; 19(11):1835-1854. PubMed ID: 33632104
[TBL] [Abstract][Full Text] [Related]
39. Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective.
Al-Kuraishy HM; Al-Gareeb AI; Negm WA; Alexiou A; Batiha GE
Inflammopharmacology; 2022 Oct; 30(5):1493-1501. PubMed ID: 35922738
[TBL] [Abstract][Full Text] [Related]
40. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
